Abstract:Lung surfactant is stored in lamellar bodies and exocytosed following fusion of the lamellar bodies with the plasma membrane of alveolar type II (AT2) cells [1]. A number of proteins have been shown to be involved in surfactant secretion including SNAREs, NSF, α-SNAP and annexin A2 [2;3]. Lipid rafts enriched in SNAREs are crucial for surfactant secretion [4]. Flotillins are lipid raft marker proteins. There are two isoforms, flotillin-1 and flotillin-2. Both are expressed in many cell types including AT2 cells [4]. Several functions of flotillins have been reported including interaction with protein kinases and the cytoskeleton; formation of filopodia; insulin signaling; axonal regeneration and cell-cell contacts and membrane trafficking [5;6]. The evidence for a role of flotillins in exocytosis is lacking except for a recent study which indicated the participation of flotillin-1 in mast cell exocytosis [7]. We investigated the functional role of flotillins in surfactant secretion by decreasing the expression of flotillin-1 and -2 using RNA interference. We used an adenoviral vector to express shRNAs because of its high transduction efficiency in primary cells. This vector contained a shRNA sequence under the control of the mouse U6 promoter and EGFP expression under the control of the CMV promoter (see Supplementary Methods). We chose 3 siRNA sequences targeted to different regions for each isoform: 118-137, 522-540 and 584-603 of flotillin-1 [F-1 shRNA (A), (B) and (C)] and 53-73, 602-620 and 1163-1182 of flotillin-2 [F-2 shRNA (A), (B) and (C)]. The construct with irrelevant sequences served as a virus control (VC). The cells which were not transduced with any virus were used as blank controls (BC). We cultured AT2 cells on an air-liquid culture system to maintain their phenotype and transduced with adenoviruses for 5 days. F-1 shRNA (A) almost completely silenced flotillin-1 expression (Fig. 1A). There was also a decrease in flotillin-2 expression although a significant amount of flotillin-2 remained in the F-1 shRNA (A)-treated AT2 cells (Fig. 1B). Among F-2 shRNAs, F-2 shRNA (C) was the most effective in silencing flotillin-2 expression. This shRNA also reduced flotillin-1 expression (Fig. 1A and B), probably because the stability of flotillin-1 is dependent on flotillin-2 [8]. Using F-1 shRNA (A) and F-2 shRNA (C), we determined the effect of flotillin-1 and -2 silencing on surfactant secretion. There were no statistically significant differences in the basal and stimulated secretions between control and F-1 shRNA (A) - treated cells (Fig. 1C). However, F-2 shRNA (C) reduced stimulated surfactant secretion. The basal secretion appears to be decreased in the F-2 shRNA (C)-treated cells but did not reach a significant level. The control virus had no effect on surfactant secretion. Figure 1 Effect of flotillin silencing on surfactant secretion We next examined whether the loss of flotillin affects lipid raft formation. Because large amounts of cells were needed for this experiment, we used L2 cells, a rat lung epithelial cell line that express flotillin-1 and -2 [4]. We transduced L2 cells with F-1 shRNA (A) or F-2 shRNA (C). Infection efficiencies increased with the multiplicity of infection (MOI) of the virus as revealed by EGFP fluorescence (Supplementary Fig. 2A). Western blot analysis indicated a significant decrease in protein expression of flotillin-1 or -2 in a dose-dependent manner (Supplementary Fig. 2B). When compared with blank and virus controls, there were no obvious differences in the amounts of protein and cholesterol of the raft fractions between control and flotillin-1 or -2 knockdown cells (Supplementary Fig. 2C and D). When cholesterol concentration was expressed as μg per μg protein, cholesterol content in the lipid raft fraction was enriched 3-, 10-, and 20-fold in comparison with non raft fractions 3, 4, and 5. SNARE proteins were enriched in lipid rafts of AT2 cells [4]. We examined whether knockdown of flotillin leads to dissociation of SNAREs with lipid rafts. Following silencing, little flotillin-1 and -2 proteins were detected in any of the fractions, indicating an effective silencing. When raft fractions were probed for two plasma membrane SNARE proteins, syntaxin-2 and SNAP-23 [2] following silencing, there was no change in the association of these proteins with lipid rafts (Supplementary Fig. 2E and F). Lipid rafts are also reported to be involved in cholesterol homeostasis. We further investigated the effects of flotillin-1 and -2 silencing on cholesterol levels in L2 cells. Following silencing of flotillin-1 and -2, cell lysates were analyzed for total cholesterol levels. Our results indicated that there were no statistical significant differences in cholesterol levels under silencing conditions when compared with controls (Supplementary Fig. 2G). We conclude that flotillin-2 is required for surfactant secretion but not via the association of SNAREs with the rafts or cholesterol homeostasis. The mechanisms of by which flotillin-2 regulates surfactant secretion remain to be determined, but could be due to its effects on signaling transduction pathways or cytosketetal rearrangement because flotillin-2 knockdown blocks the G-protein coupled Receptor (GPCR)-mediated activation of p38 MAPK [9] and trans-negative mutant flotillin-2 leads to faulty localization of Vav, resulting in altered cytoskeletal rearrangements [10].

Proteomic Profile Of Alveolar Type Ii Cell Lipid Rafts: Identification Of Novel Proteins Involved In Lung Surfactant Secretion.

Vacuolar Atpases: Insights into Lung Surfactant Secretion

Vacuolar ATPase Regulates Surfactant Secretion in Rat Alveolar Type II Cells by Modulating Lamellar Body Calcium

Effect of cholesterol depletion on exocytosis of alveolar type II cells.

Proteomic Analysis of Lamellar Bodies Isolated from Rat Lungs

Characterization of Alpha-Soluble N-Ethylmaleimide-Sensitive Fusion Attachment Protein in Alveolar Type Ii Cells - Implications in Lung Surfactant Secretion

Characterization of VAMP-2 in the lung: implication in lung surfactant secretion

Mechanosensitive Channels TMEM63A and TMEM63B Mediate Lung Inflation-Induced Surfactant Secretion

Knockdown of Flotillin-2 Inhibits Lung Surfactant Secretion by Alveolar Type II Cells

Purinergic P2X7 Receptor: A Pivotal Role in Surfactant Regulation?

Reorganization of Cytoskeleton During Surfactant Secretion in Lung Type II Cells: a Role of Annexin II

Annexin A2 Interactions with Rab14 in Alveolar Type II Cells.

Whole-Genome Analysis of Temporal Gene Expression during Early Transdifferentiation of Human Lung Alveolar Epithelial Type 2 Cells In Vitro

Novel opportunities from bioimaging to understand the trafficking and maturation of intracellular pulmonary surfactant and its role in lung diseases

The Role of Autophagy in Lamellar Body Formation and Surfactant Production in Type 2 Alveolar Epithelial Cells

Proteasome dysfunction in alveolar type 2 epithelial cells is associated with acute respiratory distress syndrome

Comparative biophysical study of clinical surfactants using constrained drop surfactometry

The expression of the surfactant proteins SP-A and SP-B during postnatal alveolarization of the rat lung

Surfactant lipidomics in healthy children and childhood interstitial lung disease

Lipidomic Analysis Probes Lipid Coronas on Hydrophilic Nanoparticles from Natural Lung Surfactant

Surfactant analysis and replacement therapy: A future tool of the lung transplant surgeon?